“Rethinking lentiviral stable producer cell lines for in vivo gene-modified cell therapies.” ASGCT, May 13-17, 2025, New Orleans

Mark your calendars, May 16 at 2:30pm at #ASGCT25!

Team ViroCell is excited to be part of the @American Society of Gene & Cell Therapy Annual Meeting in New Orleans, May 13-17!

Meet us at Booth 2052 to learn how we’re advancing vector development and manufacturing for the next generation of cell and gene therapies.

We’re proud to have a member of our Innovation Research team present new thinking around lentiviral stable producer cell lines and cell homing: “Rethinking lentiviral stable producer cell lines for in vivo gene-modified cell therapies”

by Glenda J Dickson, PhD, Senior Principal Scientist, Innovation 

Exhibit Theater
May 16, 2:30-2:45pm

and on Saturday, May 17 at 10:45am-11:00am, Glenda will present

“Serum Free Suspension HEK293 Cells Stably Expressing Gag/Pol /Rev /VSVG for Efficient Production of Lentiviral Vectors” in the Vector Product Engineering, Development and Manufacturing (excluding AAV) Session, Room: 383-385

Team ViroCell is committed to the design and development of complex viral vectors, accelerating the translation of cell and gene therapies from lab to life. Let’s connect. @Traci Kyes @Elaine Rihn

Book a meeting.

https://www.virocell.com/contact-us-form

#cellandgenetherapy #CellTherapy #GeneTherapy #advancedtherapies #viralvectors #lentiviralvectors #retroviralvectors